IP Library Granted Patent US 8,802,371
Granted Patent B2
US 8,802,371 · App. 13/630,045 · Granted Aug 12, 2014

Sequences and their use for detection and characterization of STEC bacteria

Inventors: Stephen Varkey (Newark, DE); Daniel R. DeMarco (Wilmington, DE); Mark A. Jensen (West Chester, PA)
Assignee: E. I. du Pont de Nemours and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,371
App. No.
13/630,045
Granted
Aug 12, 2014
Kind
B2
Abstract

This invention relates to a rapid method for detection and characterization of STEC bacteria based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect STEC bacteria in a food or water sample, such as a beef enrichment. The present invention further relates to isolated polynucleotides, replication compositions, kits, and reagent tablets for carrying out the method of the present invention.

Claims (27)

1. A method for detecting the presence of STEC bacteria in a sample, said sample comprising nucleic acids, said method comprising:

(a) providing a reaction mixture comprising a first primer, a second primer, and a probe for amplification and detection of at least a portion of:

(i) SEQ ID NO: 688; wherein each of said first primer for the amplification of SEQ ID NO: 688, second primer for the amplification of SEQ ID NO: 688, and probe for the detection of SEQ ID NO: 688 comprises a 5′ end and a 3′ end; wherein said first primer for the amplification of SEQ ID NO: 688 comprises at least 15 contiguous nucleotides of SEQ ID NO: 145 or a sequence complementary thereto; and wherein said probe for the detection of SEQ ID NO: 688 comprises at least 15 contiguous nucleotides of SEQ ID NO: 160 or a sequence complementary thereto; and

(ii) one or more nucleic acid sequences selected from the group consisting of:

(A) SEQ ID NO: 686; wherein each of said first primer for the amplification of SEQ ID NO: 686, second primer for the amplification of SEQ ID NO: 686, and probe for the detection of SEQ ID NO: 686 comprises a 5′ end and a 3′ end; and wherein said first primer for the amplification of SEQ ID NO: 686 and probe for the detection of SEQ ID NO: 686 are selected from the group consisting of:

(I) a first primer comprising at least 15 contiguous nucleotides of SEQ ID NO: 1 or a sequence complementary thereto and a probe comprising at least 15 contiguous nucleotides of SEQ ID NO: 16 or a sequence complementary thereto;

(II) a first primer comprising at least 15 contiguous nucleotides of SEQ ID NO: 1 or a sequence complementary thereto and a probe comprising at least 15 contiguous nucleotides of SEQ ID NO: 49 or a sequence complementary thereto; and

(III) a first primer comprising SEQ ID NO: 55 or a sequence complementary thereto and probe comprising SEQ ID NO: 56 or a sequence complementary thereto; and

(B) SEQ ID NO: 687; wherein each of said first primer for the amplification of SEQ ID NO: 687, second primer for the amplification of SEQ ID NO: 687, and probe for the detection of SEQ ID NO: 687 comprises a 5′ end and a 3′ end; and wherein said first primer for the amplification of SEQ ID NO: 687 and probe for the detection of SEQ ID NO: 687 are selected from the group consisting of:

(I) a first primer comprising at least 15 contiguous nucleotides of SEQ ID NO: 74 or a sequence complementary thereto and a probe comprising at least 15 contiguous nucleotides of SEQ ID NO: 89 or a sequence complementary thereto;

(II) a first primer comprising SEQ ID NO: 120 or a sequence complementary thereto and a probe comprising SEQ ID NO: 121 or 122 or a sequence complementary thereto; and

(III) a first primer comprising SEQ ID NO: 125 or a sequence complementary thereto and probe comprising SEQ ID NO: 126 or a sequence complementary thereto; and

(b) performing PCR amplification of said nucleic acids of said sample using the reaction mixture of step (a); and

(c) detecting the amplification of step (b).

2. The method of claim 1 , wherein said second primer for the amplification of SEQ ID NO: 688 comprises a nucleic acid sequence comprising at least 15 contiguous nucleotides of SEQ ID NO: 191 or a sequence complementary thereto.

3. The method of claim 2 , wherein said first primer for the amplification of SEQ ID NO: 688 comprises a sequence selected from the group consisting of SEQ ID NOs: 146-159, said second primer for the amplification of SEQ ID NO: 688 comprises a sequence selected from the group consisting of SEQ ID NOs: 192-205, and said probe for the detection of SEQ ID NO: 688 comprises a sequence selected from the group consisting of SEQ ID NOs: 161-175.

4. The method of claim 1 , wherein the 3′ end of said probe for the detection of SEQ ID NO: 688 is directly or indirectly attached to the 5′ end of said first primer for the amplification of SEQ ID NO: 688 forming a primer-probe complex for the amplification and detection of SEQ ID NO: 688, and wherein said primer-probe complex for the amplification and detection of SEQ ID NO: 688 is detectably labeled.

5. The method of claim 4 , wherein said reaction mixture for the amplification and detection of SEQ ID NO: 688 further comprises a quencher oligonucleotide comprising at least 15 contiguous nucleotides of SEQ ID NO: 176.

6. The method of claim 1 , wherein said second primer for the amplification of SEQ ID NO: 686 comprises a nucleic acid sequence comprising at least 15 contiguous nucleotides of SEQ ID NO: 58 or comprising SEQ ID NO: 73.

7. The method of claim 6 , wherein said first primer for the amplification of SEQ ID NO: 686 comprises a sequence selected from the group consisting of SEQ ID NOs: 2-15, 48; said second primer for the amplification of SEQ ID NO: 686 comprises a sequence selected from the group consisting of SEQ ID NOs: 59-72; and said probe for the detection of SEQ ID NO: 686 comprises a sequence selected from the group consisting of SEQ ID NOs: 17-30, 49-52.

8. The method of claim 1 claim, wherein the 3′ end of said probe for the detection of SEQ ID NO: 686 is directly or indirectly attached to the 5′ end of said first primer forming a primer-probe complex for the amplification and detection of SEQ ID NO: 686, and wherein said primer-probe complex for the amplification and detection of SEQ ID NO: 686 is detectably labeled.

9. The method of claim 8 , wherein said reaction mixture for the amplification and detection of SEQ ID NO: 686 further comprises a quencher oligonucleotide comprising SEQ ID NO: 53, 54, or 57, or comprising at least 15contiguous nucleotides of SEQ ID NO: 31.

10. The method of claim 1 , wherein said second primer for the amplification of SEQ ID NO: 687 comprises a nucleic acid sequence comprising at least 15 contiguous nucleotides of SEQ ID NO: 128 or comprising SEQ ID NO: 143 or 144.

11. The method of claim 10 , wherein said first primer for the amplification of SEQ ID NO: 687 comprises a sequence selected from the group consisting of SEQ ID NOs: 75-88; said second primer for the amplification of SEQ ID NO: 687 comprises a sequence selected from the group consisting of SEQ ID NOs: 129-144; and said probe for the detection of SEQ ID NO: 687 comprises a sequence selected from the group consisting of SEQ ID NOs: 90-104.

12. The method of claim 1 , wherein the 3′ end of said probe for the detection of SEQ ID NO: 687 is directly or indirectly attached to the 5′ end of said first primer for the amplification of SEQ ID NO: 687 forming a primer-probe complex for the amplification and detection of SEQ ID NO: 687, and wherein said primer-probe complex for the amplification and detection of SEQ ID NO: 687 is detectably labeled.

13. The method of claim 12 , wherein said reaction mixture for the amplification and detection of SEQ ID NO: 687 further comprises a quencher oligonucleotide comprising SEQ ID NO: 123, 124, or 127, or comprising at least 15 contiguous nucleotides of SEQ ID NO: 105.

14. The method of claim 1 , wherein the sample comprises a food sample or a water sample.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055644/0636 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 41983/0340 Recorded Mar 16, 2021
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055628/0366 →
SECURITY INTEREST Recorded Mar 16, 2017
From: QUALICON DIAGNOSTICS LLC, AS THE GRANTOR
To: ARES CAPITAL CORPORATION, AS SECOND LIEN ADMINISTRATIVE AGENT
Reel/Frame 041602/0334 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Mar 13, 2017
From: QUALICON DIAGNOSTICS LLC
To: ANTARES CAPITAL LP, AS FIRST LIEN ADMINISTRATIVE AGENT
Reel/Frame 041983/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2017
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 041468/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2013
From: VARKEY, STEPHEN; DEMARCO, DANIEL R.; JENSEN, MARK A.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 029821/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2013
From: VARKEY, STEPHEN; DEMARCO, DANIEL R.; JENSEN, MARK A.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 029786/0671 →
Continuity (2)
Provisional Application 61540119 · Sep 28, 2011
Related Publication 20130078634A1 · Mar 28, 2013